Daré Bioscience, Inc. completed the closing of its Regulation A offering on April 10, 2026, issuing 3,470 Investor Units at $5.00 each, consisting of Series A Convertible Preferred Stock and warrants for 6,940 common shares.
Key takeaways
Completed closing of previously announced Regulation A offering on April 10, 2026.
Issued 3,470 Investor Units, each comprising one share of Series A Convertible Preferred Stock and two Investor Warrants.
Investor Warrants allow purchase of up to 6,940 shares of common stock.
Each Investor Unit priced at $5.00.
Offering conducted pursuant to Form 1-A qualified by SEC on April 1, 2026.